Biogen to Buy Reata in $7.3 Billion Deal
Wall Street Journal
The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases.
https://www.wsj.com/articles/biogen-to-buy-reata-pharmaceuticals-in-7-3-billion-deal-512adde2